MECLAN Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Meclan, and what generic alternatives are available?
Meclan is a drug marketed by Johnson And Johnson and is included in one NDA.
The generic ingredient in MECLAN is meclocycline sulfosalicylate. There is one drug master file entry for this compound. Additional details are available on the meclocycline sulfosalicylate profile page.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for MECLAN?
- What are the global sales for MECLAN?
- What is Average Wholesale Price for MECLAN?
Summary for MECLAN
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 1 |
| Patent Applications: | 346 |
| DailyMed Link: | MECLAN at DailyMed |
US Patents and Regulatory Information for MECLAN
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Johnson And Johnson | MECLAN | meclocycline sulfosalicylate | CREAM;TOPICAL | 050518-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
